Related Experiment Videos
Pharmacologic aspects of pentamidine
National Cancer Institute Monograph
|October 1, 1976
Summary
Pentamidine, used for Pneumocystis pneumonia, may cause kidney toxicity. It inhibits dihydrofolate reductase and interacts with nucleic acids, explaining its effects and toxicity.
Area of Science:
- Pharmacology
- Toxicology
- Microbiology
Background:
- Pentamidine is an aromatic diamidino compound initially developed for trypanosomiasis treatment.
- Its pharmacological effects differ based on administration route, with intravenous (IV) administration causing transient hypotension and intramuscular (IM) administration being preferred in humans to avoid this.
- Pentamidine has gained importance for treating Pneumocystis carinii pneumonia (PCP), particularly in immunocompromised patients.
Purpose of the Study:
- To investigate the pharmacological effects and toxicity of pentamidine.
- To elucidate the mechanism of action of pentamidine against Pneumocystis carinii.
- To understand the tissue distribution, excretion, and toxicity of pentamidine.
Main Methods:
- Animal studies were conducted to assess pharmacologic effects, including blood pressure changes and renal toxicity.
- Distribution and excretion studies in animals were performed.
- In vitro and in vivo experiments were utilized to investigate the mechanism of action, including enzyme inhibition and interactions with nucleic acids.
Main Results:
- Pentamidine administration in animals led to transient hypotension and renal toxicity with repeated dosing.
- Tissue distribution studies showed pentamidine deposition, primarily in the kidneys, with slow elimination.
- Investigations revealed that pentamidine inhibits dihydrofolate reductase in various tissues and forms insoluble complexes with nucleotides and nucleic acids.
Conclusions:
- Pentamidine's mechanism of action involves dihydrofolate reductase inhibition and interaction with nucleic acids, contributing to its therapeutic effects and potential toxicity.
- Understanding these mechanisms is crucial for managing pentamidine therapy and mitigating adverse events, especially renal toxicity.
- Further research is needed to fully clarify the relationship between pentamidine's tissue fixation, its mechanism of action, and observed toxicities.